Figure 4. Incidence of death, myocardial infarction, or stroke in patients who received genotype‐guided or conventional therapy by ABCD‐GENE score groups.

At 1 year, the risk of death, myocardial infarction, or stroke was not significantly reduced in the genotype‐guided therapy arm compared with the conventional therapy in both the high and low ABCD‐GENE score g subgroups. ABCG‐GENE denotes Age, Body Mass Index, Chronic Kidenye Disease, Diabetes, and Genotyping; CVA, cerebrovascular accidents; HR, hazard ratio; and MI, myocardial infarction.